Novavax
NVAX
#2560
Rank
$4.05 B
Marketcap
$48.00
Share price
-7.50%
Change (1 day)
-65.75%
Change (1 year)

Revenue for Novavax (NVAX)

Revenue in 2021 (TTM): $1.14 B

According to Novavax's latest financial reports the company's current revenue (TTM) is $1.14 B. In 2020 the company made a revenue of $0.47 B an increase over the years 2019 revenue that were of $0.01 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novavax from 2001 to 2021

Year Revenue Change
2021 (TTM)$1.14 B141.02%
2020$0.47 B2448.48%
2019$0.01 B-45.57%
2018$0.03 B9.98%
2017$0.03 B103.06%
2016$0.01 B-57.65%
2015$0.03 B18.24%
2014$0.03 B46.6%
2013$0.02 B-5.26%
2012$0.02 B50.3%
2011$0.01 B4182.22%
2010$0.34 M5.54%
2009$0.32 M-69.45%
2008$1.06 M
2006$4.68 M-36.61%
2005$7.38 M-17.21%
2004$8.92 M-24.28%
2003$0.01 B-21.45%
2002$0.01 B-37.65%
2001$0.02 B